Centene: Further Upside Will Require Better Execution

Centene rebounded in Q1-2026 with a significant improvement in its health benefits ratio, dropping to 87.3% from 94.3% in Q4-2025. CNC's Medicaid HBR improvement was driven by rate increases, medical cost management, and a mild flu season, though management remains cautious on sustainability. Despite a strong Q1-2026 beat, CNC raised full-year guidance less than the quarterly outperformance, reflecting uncertainty about trend continuation.